MARANATH GRAUGNARD: Open Payments
NPI 1932461944 · ZACHARY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 12 payments from 5 companies in 2025. Trend: 2023 $188 · 2024 $415 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $160 |
| CooperSurgical, Inc. | 1 | $33 |
| Exeltis, USA Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: Veozah, Paragard T 380A, SLYND, Mirena, MYFEMBREE.
Industry payments across LA — which companies pay providers there.
